Daily Coverage San Diego August 2014


Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Results of ESBA 1008, a Single-Chain Antibody Fragment, for the Treatment of Neovascular AMD

by Pravin Dugel, MD

Pravin Dugel, MD, from Retinal Consultants of Arizona, shares study results on ESBA 1008, a single-chain antibody fragment with potential applications in targeting VEGF.

5,886 video views since .
49,108 total series views.

Comments (0)